Medical Equipment

Oncology Devices Market Insights On Growth Drivers, Trends, And Opportunities

April 15, 2026April 15, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Oncology Devices Market During 2026–2030?

The oncology devices market scale has expanded quickly in recent times. This market is projected to expand from $177.72 billion in 2025 to $210.15 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 18.2%. Historically, this expansion can be linked to several factors, including a rise in global cancer occurrence rates, the enlargement of hospital oncology divisions, an increasing need for technologies facilitating early diagnosis, the presence of sophisticated imaging solutions, and heightened awareness campaigns for cancer screening.

The oncology devices market size is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $397.27 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.3%. Factors contributing to this growth during the forecast period include the increasing adoption of personalized cancer treatment devices, greater investments in oncology infrastructure, the expansion of outpatient cancer treatment facilities, the growing application of AI-driven diagnostic tools, and an enhanced focus on precision oncology solutions. Key trends expected within this period involve the increasing uptake of advanced cancer diagnostic devices, the rising utilization of image-guided oncology therapies, the expanding integration of minimally invasive cancer treatment tools, the broadening of precision radiation therapy equipment, and a heightened emphasis on early cancer detection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Which Strong Drivers Are Impacting The Oncology Devices Market Growth?

The oncology devices market is anticipated to expand due to the escalating need for chemotherapy. Chemotherapy, a cancer therapy, utilizes potent medications to eliminate fast-multiplying cells, thereby inhibiting or halting tumor progression and dissemination. The global surge in cancer cases is driving this demand, as a higher number of diagnoses necessitates accessible and effective treatments capable of addressing various cancer types and stages. Oncology devices play a crucial role in chemotherapy by facilitating safer, more accurate drug administration and vigilant monitoring, thereby improving treatment efficacy and patient results. For example, the U.S. National Cancer Institute, a federal cancer research agency based in the U.S., forecasts that new cancer cases in the United States will climb to 2.04 million in January 2025, an increase from 1.96 million in 2023, underscoring the growing requirement for chemotherapy delivery systems. Consequently, the expanding demand for chemotherapy is fueling the advancement of the oncology devices market.

How Is The Oncology Devices Market Organized By Segment Classification?

The oncology devices market covered in this report is segmented –

1) By Device Type: Brachytherapy Devices, Endoscopic Devices

2) By Therapy: Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radition Therapy

3) By End User: Hospitals, Cancer Research Institutes, Other End Users

Subsegments:

1) By Brachytherapy Devices: Afterloaders (High-Dose Rate (HDR) And Low-Dose Rate (LDR)), Applicators, Seeds, Accessories

2) By Endoscopic Devices: Endoscopes (Flexible, Rigid, Capsule), Endoscopic Ultrasound Systems, Endoscopic Accessories

Which Trends Are Contributing To Changes In The Oncology Devices Market?

Leading companies in the oncology devices market are concentrating on developing sophisticated, precision-focused solutions aimed at boosting treatment accuracy, ensuring patient safety, and enhancing clinical workflow efficiency. These innovations prioritize minimally invasive technologies, augmented visualization, and real-time therapy optimization to facilitate improved outcomes across various types of cancer. For example, in April 2025, ZEISS, a medical technology company based in Germany, obtained FDA 510(k) clearance for its INTRABEAM 700 system. This system is a next-generation robotic-assisted intraoperative radiotherapy (IORT) platform specifically engineered for targeted radiation delivery during neuro-oncology and breast cancer procedures. The INTRABEAM 700 provides enhanced precision, optimized ergonomics, and better integration into surgical workflows, allowing clinicians to administer localized radiation during surgery while simultaneously minimizing exposure to surrounding healthy tissue. By incorporating state-of-the-art imaging, robotics, and treatment-planning functionalities, the INTRABEAM 700 improves therapeutic exactness, supports more rapid clinical decision-making, and aligns with the industry’s ongoing transition toward technologically advanced, patient-centered oncology care.

Who Are The Industry Participants Involved In The Oncology Devices Market?

Major companies operating in the oncology devices market are Eckert & Ziegler BEBIG GmbH, Oncura Inc., GE Healthcare, Medtronic plc, Varian Medical Systems Inc., Elekta AB, Theragenics Corporation, Accuray Incorporated, Roche Diagnostics, IBA Group, Biogenex Laboratories, Becton Dickinson and Company, Siemens Healthineers, Philips Healthcare, Hologic Inc., IBA AG, ViewRay Inc., Canon Medical Systems Corporation, Brainlab, PerkinElmer, RaySearch Laboratories, Mevion Medical Systems, Vision RT, IsoRay, RefleXion Medical, Alpha Tau Medical, Nanobiotix, Mirada Medical Ltd., Navidea Biopharmaceuticals Inc.

Get The Full Oncology Devices Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Which Region Leads The Oncology Devices Market In Overall Market Size?

North America was the largest region in the oncology devices market in 2025. Asia-Pacific was the second-largest region in the oncology devices market report. The regions covered in the oncology devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oncology Devices Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/oncology-devices-global-market-report

Browse Through More Reports Similar to the Global Oncology Devices Market 2026, By The Business Research Company

Interventional Oncology Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/interventional-oncology-devices-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795